Investor Day November 15, 2019 Investor Relations
[email protected] FOR INVESTOR USE ONLY Agenda 1. Our Strategy 7. Interventional Solutions Dow Wilson, President & Chief Executive Officer Gary Bischoping, President, Interventional Solutions* Frank Facchini, M.D., Chief Medical Officer, 2. Oncology Systems Interventional Solutions Chris Toth, President, Oncology Systems 8. Financial Update Gary Bischoping, President, Interventional Solutions* 3. CTSI J. Michael Bruff, Chief Financial Officer* Andrew Shogan, SVP, CTSI 9. Q&A 4. Software Solutions Corey Zankowski, Ph.D., SVP, Oncology Software Solutions 10. Closing Remarks Dow Wilson, President & Chief Executive Officer 5. Break 6. Proton Solutions & Emerging Businesses Kolleen T. Kennedy, President, Proton Solutions and Chief Growth Officer Dee Khuntia, M.D., Chief Medical Officer 2 FOR© 2019. INVESTOR Varian Medical USE ONLY Systems, Inc. For immediate recipient only. *Effective December 1, 2019 Overview & Strategy Dow Wilson, President & Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking Statements Except for historical information, this presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers, future trends in cancer incidence and trends in cancer treatment needs, demand, innovation and growth opportunities; Varian Medical System, Inc.’s (”Varian” or the “company”)